Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001470831-25-000187
Filing Date
2025-09-11
Accepted
2025-09-11 17:45:52
Documents
2
Period of Report
2025-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1757627149.html 4  
1 FORM 4 wk-form4_1757627149.xml 4 7243
2 EX-24.2 SUBSTITUTE POWER OF ATTORNEY centessasubstitutepoa.txt EX-24 1923
  Complete submission text file 0001470831-25-000187.txt   10843
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM CHESHIRE United Kingdom WA14 2DT
Business Address
Accardi Mario Alberto (Reporting) CIK: 0002074392 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40445 | Film No.: 251309487